Conjugate Therapy Produces Remissions in One-Third of Patients with Drug-Resistant Ovarian Cancer, Study Results Show
Drug Combination Shows Effectiveness in Patients with Recurrent ER-Positive Endometrial Cancer
Study: Antibody Response Varies by Tumor Type and Treatment
Roswell Park Opens Phase 2B Randomized Clinical Trial of Promising Brain Cancer Immunotherapy
Researchers Identify Promising Drug Target in Pediatric Neuroblastoma
USC Norris Comprehensive Cancer Center launches global clinical trial testing potential therapy for aggressive type of breast cancer
Data Reveals Promising New First-Line Treatment for Newly Diagnosed Colon Cancer
Cancer neuroscientists identify a key culprit behind pediatric brain cancer’s spread
Penn Medicine Awarded $12.3M NIH Grant to Study Ultra-Fast, High-Dose FLASH Radiation Therapy for Cancer
Dana-Farber/Boston Children’s Exceeds Expected Outcomes for Stem Cell Transplants
Dana-Farber Researchers Present Findings at 2022 ASCO Genitourinary Cancers Symposium
A Case of Mistaken Identity: Researchers Unmask Cellular Source of Barrett’s Esophagus
Pivotal Clinical Trials Advancing Rectal Cancer Treatment
Study of Penn Patients with Decade-Long Leukemia Remissions after CAR T Cell Therapy Reveals New Details About Persistence of Personalized “Living Drug” Cells
Baptist Health’s Miami Cancer Institute named as 2022 Recipient of Warren E. Weaver/Richard P. Penna Award
Showing 436 - 450 of 987 results
Previous| 1... 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 ...66 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
